Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DeepVerge Collaboration for Water & Soil Analysis

23 Aug 2021 07:00

RNS Number : 3801J
Microsaic Systems plc
23 August 2021
 

 

RNS Reach

 

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic collaborates with DeepVerge plc to launch range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil

 

Combined micro-engineering technology, software and AI create unique identification detection system for Chemicals of Emerging Concern[i] (CEC) including Forever Chemicals[ii] (PFAS)

 

Microsaic (AIM:MSYS), is pleased to announce continued progress through its collaboration with DeepVerge plc ("DeepVerge") (AIM: DVRG) to provide real-time monitoring solutions to detect and identify contaminants in water and soil.

 

Microsaic has launched a miniaturised mass spectrometer platform which provides fully integrated front-end solutions, with software upgrades using AI from DeepVerge, to achieve triple quadrupole limits of detection for real-time monitoring and identification of organic chemicals in water and soil. 'Triple quad' limits of detection mean increased sensitivity and specificity, which allows detection and quantitation at lower limits than conventional single quadrupole mass spectroscopy.

 

In collaboration with DeepVerge plc environmental division, who has implemented real-time services for the automated detection and identification of metals and pathogens[iii], Microsaic augments this offering now with automated real-time detection and expert analysis of dangerous organic chemicals in water and soil.

 

· Detection capability for a variety of contaminants and toxic bad actors adds:

o Organic chemical expertise and detection of CECs, currently unregulated and unmeasured, with the European Chemical Agency in 2020 identifying 290 chemical candidates for regulatory action by the European Commission[iv]

· New platform augments revenue channels of both companies without re-engineering business infrastructure:

o Screening - project deployment (e.g. site remediation, clean up, chronic or acute spills), mobile laboratory/van etc.

o Monitoring - site surveillance (e.g. waste water treatment plants, sites of special interest)

· Retrofit or standalone integration of high-tech hardware, software and AI adds:

o Unified data handling

o Unified/integrated sampling strategies

o Unified front-end to customers installations and collaborations

o Powerful and accurate analysis of aggregated data with AI delivering the ability to detect an array of targets in a single platform and with predictive alert capability

 

The new portable Microsaic platform, with triple quadrupole limits of detection is unique, bringing laboratory quality performance to the front-line, at a fraction the cost and up to 90% smaller than traditional triple quadrupole mass spectrometry equipment, reducing workflows and allowing real-time manual, or automated, decision making in real-time.

 

Glenn Tracey, CEO of Microsaic Systems plc, commented:

"The Microsaic team has achieved two major milestones: first, a range of miniaturised portable mass spectrometry systems with triple quadrupole limits of detection, and second, access to potential new sources of shared income from monitoring services that offer protection to society against the silent killer of chemicals of emerging concern."

 

"This combination of capabilities from Microsaic and DeepVerge provides impressive coverage between chemicals and pathogens in our waters and soil. The Microsaic Board believes that data-driven monitoring capability is of great interest to government, industrial and agricultural stakeholders which is already generating significant interest from prospective clients."

 

 

Gerard Brandon, DeepVerge plc CEO, commented:

"By combining our expertise in contaminant monitoring, we are able to offer new, innovative real-time monitoring solutions to our existing customers and open new global opportunities for fully-integrated water and soil detection of a broad range of pathogens and chemicals. This includes detecting the presence of COVID-SARS-CoV-2, providing the potential to identify virus hotspots more rapidly and cost effectively than by direct human testing."

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking) 

Turner Pope Investments (TPI) Limited(Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

About Microsaic (www.microsaic.com)

 

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications. 

 

About DeepVerge plc (www.deepverge.com)

 

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 


[i] https://www.microsaic.com/news/the_truth_about_the_silent_undetected_killers_in_our_waters/

[ii] https://www.microsaic.com/news/5-enivronmental-issues-real-time-diagnosis-can-help-solve/

[iii] Pathogens (virus, bacteria, toxins and parasites)

[iv] https://echa.europa.eu/-/nearly-300-chemicals-identified-as-candidates-for-regulatory-action

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDICBDDGBG
Date   Source Headline
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award
8th Jun 201210:53 amRNSHolding(s) in Company
7th Jun 20127:00 amRNSHolding(s) in Company
30th May 20123:40 pmRNSHolding(s) in Company
30th May 201211:36 amRNSAGM Results
29th May 201210:35 amRNSHolding(s) in Company
29th May 20127:00 amRNSPlacing
11th May 20129:18 amRNSHolding(s) in Company
9th May 20127:00 amRNSRe Agreement
30th Apr 20122:22 pmRNSDistribution of Annual Report and Accounts
25th Apr 20127:00 amRNSPreliminary Results
18th Apr 201210:07 amRNSMicrosaic Exhibits at Analytica 2012
22nd Feb 201211:21 amRNSHolding(s) in Company
12th Dec 20117:00 amRNSDirectorate Change
25th Nov 20119:04 amRNSExercise of Share Options
2nd Nov 20118:59 amRNSHolding(s) in Company
5th Oct 20119:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.